News and Announcements
Phylogica patents technology to discover sophisticated cell-penetrating drugs
- Published June 27, 2013 9:46AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
PERTH, AUSTRALIA: 27 June 2013 – Leading peptide drug discovery company Phylogica Ltd (ASX: PYC, XETRA: PH7) has developed and patented an enhancement to its Phylomer® peptide platform to discover more sophisticated cell-penetrating drugs to help tackle disease.
This new component of Phylogica’s technology will enable more efficient screening of its library of billions of naturally occurring peptides to identify and capture those with greatest potential to target disease proteins inside of cells.
To develop a new generation of therapies, there is global demand for novel peptides that can effectively deliver biologics drugs to cells where most targets reside. These peptides need to:
- penetrate natural cell membrane barriers
- target particular parts of the cell such as nuclei, and
- ensure that drug cargos are not trapped in endosomes.
Phylogica’s technology satisfies these criteria by identifying effective cell-penetrating peptides that can deliver targeted therapeutic drug cargos to a desired location.
To read the ASX announcement, please download the document below.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
